Icon

PriceIcon

ICLR

Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.

Historical stock price chart and annual return over the past years

13%

5 years

% Total

ICLR
2%

5 years

Annual Return

ICLR